Order results by:
Issue | Title | |
Vol 5, No 1 (2012) | DYNAMICS OF PREFERENTIAL MAINTENANCE OF CITIZENS WITH ANTIHYPERTENSIVE DRUGS AT THE EXPENSE OF THE REGIONAL BUDGET | Abstract similar documents |
I. I. Lavrentyeva, A. I. Khokhlov, I. N. Kagramanyan, T. A. Gorokhova | ||
"... on medicinal maintenance lays down on the regional budget. The analysis of dynamics of maintenance sick ..." | ||
Vol 11, No 2 (2018) | Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia | Abstract similar documents |
I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina | ||
"... The aim: to provide a comprehensive pharmacoeconomic evaluation of the maintenance therapy ..." | ||
Vol 11, No 1 (2018) | Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia | Abstract similar documents |
I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina | ||
"... The aim: to provide a comprehensive pharmacoeconomic evaluation of the antipsychotic maintenance ..." | ||
Vol 13, No 2 (2020) | Pharmacoeconomic analysis of tiotropium bromide and olodaterol fixed combination as maintenance therapy for patients with COPD in the Russian Federation | Abstract similar documents |
S. V. Nedogoda, M. Yu. Frolov, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova | ||
"... ) in comparison with other medications, included in the Vital and Essential Drugs List (VEDL), for the maintenance ..." | ||
Vol 9, No 3 (2016) | CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY | Abstract similar documents |
E. A. Pyadushkina, M. Yu. Frolov | ||
"... , for the account of healthcare and social security budget of the constituent members of the Russian Federation; 2 ..." | ||
Vol 12, No 2 (2019) | Health technology assessment and reimbursement of pharmaceuticals in Italy | Abstract similar documents |
F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan | ||
"... technologies is taken into consideration for decision-making, in practice, the main focus rests on the budget ..." | ||
Vol 6, No 4 (2013) | Pharmacoeconomic analysis of Anti-inhibitor coagulant complex (AICC) in the treatment of inhibitor hemophilia | Abstract similar documents |
R. I. Yagudina, I. Yu. Zinchuk | ||
"... позволит в рамках текущего бюджета системы здравоохранения дополнительно пролечить 34 больных данной ..." | ||
Vol 6, No 3 (2013) | PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER | Abstract similar documents |
R. I. Yagudina, I. Yu. Zinchuk | ||
Vol 9, No 3 (2016) | DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY | Abstract similar documents |
M. V. Avxentyeva, V. I. Bogin, E. V. Derkach, V. V. Omelyanovskiy, M. B. Stenina, A. V. Tarakanov, M. Yu. Frolov | ||
"... from federal and regional budgets in 2013 in the regions of the Russian Federation for patients ..." | ||
Vol 10, No 1 (2017) | PHARMACOECONOMIC ANALYSIS OF BRENTUXIMAB VEDOTIN THERAPY IN RELAPSED OR REFRACTORY CD30+ SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA IN PATIENTS OVER 18 YEARS OF AGE: HEALTH BUDGET IMPACT ANALYSIS | Abstract similar documents |
A. S. Kolbin, I. A. Vilum, М. A. Proskurin, Yu. E. Balykina | ||
"... . Recommendations to carry out a budget impact analysis in theRussian Federation (2016) were used. Results ..." | ||
Vol 12, No 1 (2019) | Economic consequences of healthcare optimization for IBD patients in the Republic of Tatarstan | Abstract similar documents |
T. P. Bezdenezhnykh, D. V. Fedyaev, G. R. Khachatryan, G. G. Arutyunov, K. V. Gerasimova | ||
"... optimization in the Republic of Tatarstan. Materials and methods. A budget impact model was created to compare ..." | ||
Vol 7, No 3 (2014) | ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION | Abstract similar documents |
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva | ||
"... supported by involvement of federal budget funds, to define the list of orphan drugs, to implement state ..." | ||
Vol 9, No 2 (2016) | PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION | Abstract similar documents |
T. V. Gaygolnik, I. V. Demko, E. N. Bochanova, A. Yu. Kraposhina, N. V. Gordeeva, I. A. Soloveva | ||
"... Целью исследования было проведение анализа структуры и рациональности затрат на обеспечение ..." | ||
Vol 11, No 3 (2018) | Pharmacoeconomic analysis of using belimumab for the treatment of systemic lupus erythematosus | Abstract similar documents |
A. G. Tolkushin, N. L. Pogudina | ||
"... наблюдательных исследованиях. Цены лекарственных препаратов получены на основании регистра цен ЖНВЛП. Медицинские ..." | ||
Vol 10, No 1 (2017) | BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE: BUDGET IMPACT ANALYSIS | Abstract similar documents |
E. A. Pyadushkina | ||
"... лекарственных препаратов (ЛП) из перечня жизненно необходимых и важнейших лекарственных препаратов (ПЖНВЛП ..." | ||
Vol 5, No 3 (2012) | PHARMACOECONOMIC STUDY OVER USE OF ANTICHOLINERGIC BRONCHODILATORS (SPIRIVA AND ATROVENT) FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
A. U. Kulikov, I. A. Komarov | ||
"... of this group of patients. We performed budget impact analysis on the basis of two bronchodilators in Russian ..." | ||
Vol 10, No 1 (2017) | EVALUATION OF DRUG THERAPY IN PROGRESSING DIFFERENTIATED THYROID CANCER REFRACTORY TO RADIOACTIVE IODINE IN PATIENTS RESIDING IN THE RUSSIAN FEDERATION : PHARMACOECONOMIC ASPECTS | Abstract similar documents |
M. Yu. Frolov, V. A. Rogov | ||
"... to radioactive iodine in patients – residents of the Russian Federation. Materials and Methods. The budget ..." | ||
Vol 8, No 4 (2015) | CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS | Abstract similar documents |
E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva | ||
"... for the cost-minimization analysis (model 1) and analysis of the budget impact TRA usage (model 2 ..." | ||
Vol 12, No 4 (2019) | Pharmacoeconomic analysis of using biological agents for uncontrolled moderate-to-severe atopic asthma in the Russian Federation | Abstract similar documents |
S. K. Zyryanov, I. N. Diyakov, S. N. Avdeev | ||
"... . Budget impact analysis for the partial replacement of omalizumab with mepolizumab and/or reslizumab has ..." | ||
Vol 10, No 2 (2017) | COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD | Abstract similar documents |
E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov, N. L. Bondarenko, A. V. Karaulov | ||
"... / umeclidinum bromide and olodaterol / tiotropium bromide, and evaluate the ways of minimizing health budget ..." | ||
Vol 13, No 4 (2020) | Pharmacoeconomic feasibility of using the drug Hemangiol (propranolol, oral solution) in the treatment of proliferating infantile hemangioma requiring systemic therapy | Abstract similar documents |
I. N. Dyakov, S. R. Varfolomeеva | ||
"... -effectiveness analysis) with a sensitivity analysis; and a "budget impact" analysis with a sensitivity analysis ..." | ||
Vol 9, No 2 (2016) | BUDGET IMPACT ANALYSIS OF PERAMPANEL FOR ADJUNCTIVE TREATMENT IN EPILEPSY PATIENTS 12 YEARS OF AGE AND OLDER FOR PARTIAL ONSET SEIZURES WITH OR WITHOUT SECONDARY GENERALIZATION AND PRIMARY GENERALIZED TONIC-CLONIC SEIZURES IN THE RUSSIAN FEDERATION | Abstract similar documents |
V. R. Mkrtchyan, A. M. Sergeev, K. I. Pochigaeva, I. A. Shpak | ||
"... Objectives. To assess the incremental budget impact (BI) of using of utilizing perampanel to treat ..." | ||
Vol 10, No 4 (2017) | IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET | Abstract similar documents |
V. A. Lemeshko, N. Z. Musina, V. K. Fedyaeva | ||
"... of the national budget. In this article, we propose a novel concept of price control relevant to Russia, which ..." | ||
Vol 11, No 2 (2018) | Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia | Abstract similar documents |
N. A. Avxentyev, M. Yu. Frolov, A. S. Makarov | ||
"... costeffectiveness analysis and budget-impact analysis reflected the local practice and the drug reimbursement ..." | ||
Vol 12, No 4 (2019) | Pharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer | Abstract similar documents |
N. A. Avxentyev, E. V. Lubennikova, M. Yu. Frolov | ||
"... consisted of two parts: clinical and economic study and budget impact analysis. We used cost minimization ..." | ||
Vol 12, No 4 (2019) | The health technology assessment system in Australia | Abstract similar documents |
V. V. Omelyanovskiy, E. S. Saybel, T. P. Bezdenezhnykh, G. R. Khachatryan | ||
"... by the federal budget. The drug evaluation process includes five stages: a review of general information about ..." | ||
Vol 9, No 1 (2016) | PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION | Abstract similar documents |
M. Yu. Frolov, V. A. Rogov | ||
"... -effectiveness ratio (CER) and budget impact analysis (BIA) were performed. All calculations were made in the MS ..." | ||
Vol 6, No 4 (2013) | Pharmacoeconomic analysis of fluid therapy in the treatment of patients with peritonitis | Abstract similar documents |
R. I. Yagudina, M. M. Murashko | ||
"... and Sterofundin drugs were compared during the analysis. A cost analysis, cost-effectiveness analysis, budget ..." | ||
Vol 5, No 2 (2012) | PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH COMBINATIONS OF PROSTAGLANDIN ANALOGUES AND BETA-BLOCKERS | Abstract similar documents |
A. Yu. Kulikov, V. G. Serpikov | ||
"... analogues and beta-blockers by mean of cost-efficacy and budget impact analysis. Results have shown ..." | ||
Vol 5, No 3 (2012) | PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS | Abstract similar documents |
M. V. Protsenko | ||
"... minimization and budget impact analysis was conducted. Results have shown, that Azarga has benefits compare ..." | ||
Vol 10, No 3 (2017) | Initiation and intensification of insulin therapy in patients with type 2 diabetes mellitus: a budget impact analysis | Abstract similar documents |
E. V. Biryukova, V. I. Ignat’eva | ||
"... the federal healthcare budget. Materials and Methods. Based on the results of the DURABLE clinical trial, we ..." | ||
Vol 6, No 4 (2013) | Pharmacoeconomical assessment of сerebrolysin in the treatment of the acute disturbances of cerebral circulation | Abstract similar documents |
A. Yu. Kulikov, L. A. Komarov | ||
"... , the results of budget impact analysis illustrate that including сerebrolysin into the standard therapy ..." | ||
Vol 8, No 1 (2015) | BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD | Abstract similar documents |
A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina | ||
"... We have performed the first-ever Budget Impact Analysis (BIA) in a Russian context of bendamustine ..." | ||
Vol 10, No 2 (2017) | COMPARATIVE COST-MINIMIZATION AND BUDGET-IMPACT ANALYSIS OF FIXED-DOSE INHALED CORTICOSTEROID / LONG-ACTING BETAAGONIST COMBINATIONS IN THE TREATMENT OF ASTHMA | Abstract similar documents |
N. L. Pogudina, E. G. Kosolapov, F. S. Kochenkov, A. V. Karaulov, N. L. Bondarenko, D. V. Blinov | ||
"... . Retrospective comparative pharmacoeconomic study; cost-minimization analysis and budget-impact analysis ..." | ||
Vol 10, No 2 (2017) | PHARMACOECONOMIC EVALUATION OF POMALIDOMIDE (IMNOVID) FOR THE TREATMENT OF RECURRENT AND REFRACTORY MULTIPLE MYELOMA | Abstract similar documents |
M. Yu. Frolov, O. V. Shatalova | ||
"... – effectiveness analysis, budget impact analysis (in relation to the State Guarantees Program) as well ..." | ||
Vol 12, No 2 (2019) | Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available | Abstract similar documents |
F. V. Gorkavenko, A. V. Nikitina, E. S. Saibel’, M. V. Avksent’eva, M. V. Sura, D. V. Fedyaev | ||
"... the size of savings and the possibility of their redistribution within the budget framework. ..." | ||
Vol 12, No 3 (2019) | Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support | Abstract similar documents |
E. V. Eliseeva , E. S. Maneeva , R. K. Goncharova , A. V. Kropotov | ||
"... ». Обсуждение. Импортозамещение в льготном сегменте лекарственного обеспечения – сложный динамический процесс ..." | ||
Vol 10, No 2 (2017) | COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD | Abstract similar documents |
E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov | ||
"... therapy, the total budget savings can reach more than 327 million rubles. Conclusion. The use ..." | ||
Vol 10, No 1 (2017) | RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION | Abstract similar documents |
M. V. Sura | ||
"... формирование государственной политики в области лекарственного обеспечения населения РФ. Детально рассмотрены ..." | ||
Vol 6, No 2 (2013) | PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH CARBONIC ANHYDRASE INHIBITORS | Abstract similar documents |
A. Yu. Kulikov, V. G. Serpik | ||
"... by mean of costefficacy and budget impact analysis. Results have shown, that Azopt has benefits compare ..." | ||
Vol 8, No 3 (2015) | GOVERNMENTAL FUNDING OF BIOMEDICAL RESEARCH IN THE UNITED STATES OF AMERICA, GREAT BRITAIN AND GERMANY | Abstract similar documents |
G. R. Khachatrtyan, O. Yu. Rebrova, V. V. Omelyanovskiy | ||
"... of the governmental budget in biomedical research and about focus themes within biomedical research founded in open ..." | ||
Vol 12, No 2 (2019) | Pharmacoeconomic analysis of ceftazidime+avibactam (Zavicefta®) in the treatment of sepsis caused by carbapenem-resistant enterobacteria | Abstract similar documents |
S. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova | ||
"... . The economic assessment was made using the cost-effectiveness analysis and budget impact analysis. The cost ..." | ||
Vol 12, No 4 (2019) | Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation | Abstract similar documents |
A. V. Nikitina, F. V. Gorkavenko, Y. S. Saybel, M. V. Avxentyeva, M. S. Sura, D. V. Fedyaev | ||
"... Цель – оценка возможности оптимизации расходов на лекарственное обеспечение онкологических больных ..." | ||
Vol 10, No 1 (2017) | THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES | Abstract similar documents |
N. Z. Musina, V. K. Fedyaeva | ||
"... better decision-making on financing the medical treatment within a limited budget. With this algorithm ..." | ||
Vol 11, No 4 (2018) | Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions | Abstract similar documents |
G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina | ||
"... ,65%, при этом доля первичных снизилась на 1,2%. Общий объем затрат на лекарственное обеспечение пациентов ..." | ||
Vol 10, No 3 (2017) | The strategies of drug supply for patients with chronic hepatitis C | Abstract similar documents |
E. V. Kornilova, A. D. Ermolaeva, M. G. Rusanova, D. A. Andreev, M. V. Davydovskaya, T. N. Ermolaeva, A. g Pokatilo, K. I. Polyakova, V. A. Dubovtseva, K. А. Kokushkin, A. V. Devyatkin | ||
"... В статье рассмотрены варианты лекарственного обеспечения пациентов с хроническим вирусным гепатитом ..." | ||
Vol 10, No 4 (2017) | THE INTERNATIONAL PRACTICE OF DRUG SUPPLY IN THE OUTPATIENT SEGMENT | Abstract similar documents |
D. V. Lukyantseva, L. S. Mel’nikova, A. P. Tatarinov | ||
"... столкнулись страны, применяющие различные системы лекарственного обеспечения населения при амбулаторном ..." | ||
Vol 7, No 4 (2014) | ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS | Abstract similar documents |
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentieva | ||
"... лекарственного обеспечения населения за счет средств системы здравоохранения РФ. Методика исследования ..." | ||
Vol 13, No 2 (2020) | Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871 | Abstract similar documents |
V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan | ||
"... применения является одной из ключевых задач стратегии лекарственного обеспечения населения РФ до 2025 г. С ..." | ||
Vol 5, No 2 (2012) | MEDICO-ECONOMIC SUBSTANTIATION OF NORMATIVE STANDARD OF SUPPLYING STUDENTS OF MILITARY SCHOOLS WITH MEDICATIONS | Abstract similar documents |
Yu. V. Miroshnichenko, V. S. Gaynov | ||
"... , устанавливающего норму снабжения лекарственными препаратами и материалами для терапевтической стоматологии ..." | ||
1 - 50 of 171 Items | 1 2 3 4 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)